SMARCA4 and colonic neoplasm: Similarly, BRG1 loss was also statistically correlated with increased expression of Vimentin (~4-fold; two-tailed t-test, p = 8.4E-04), and the largest changes were observed in liver and colon tumors (10-fold and 6-fold, respectively; p = 4E-03 and p = 2E-02, respectively).